On both a growth and income front, Kinder Morgan Inc. (NYSE:KMI) remains a positive play for Steyer, adding double-digit price appreciation in the past twelve months to the already impressive dividend yield of 4%. KMI recently released a positive outlook for 2013 that included projections to up their dividend payout, as well as takeover news to acquire Copano Energy for about $5bn. This would both leverage and increase their presence in the southern U.S. after the deal closes in Q3 2013. Billionaire Stephen Mandel of Lone Pine Capital has seen his position swell into the nine-figures (check out what else he invests in here).
Healthcare company Sanofi SA (NYSE:SNY) finishes our list with an admirable 3.4% dividend yield. Analysts on Wall Street love SNY for their large catalog of branded drugs, even despite patent losses for some of their cancer drugs like Taxotere. SNY is highly recommended as a buy, with more than two-thirds of analysts favoring purchasing the stock. Their valuations are ambitious as well, potentially giving the stock 10% room to grow from current levels of $47.82. Fellow billionaire Ken Fisher has nearly 14mm shares of the SNY as of his last 13F filing (see which other heavy-weight positions Fisher Asset Management disclosed here).
Disclosure: I do not own shares of any stocks mentioned in this article.
Note: Tom Steyer retired at the end of 2012 but this article is based on Farallon’s Q3 13F filing.